190 related articles for article (PubMed ID: 25483102)
1. Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype.
Dong X; Lin Q; Aihara A; Li Y; Huang CK; Chung W; Tang Q; Chen X; Carlson R; Nadolny C; Gabriel G; Olsen M; Wands JR
Oncotarget; 2015 Jan; 6(2):1231-48. PubMed ID: 25483102
[TBL] [Abstract][Full Text] [Related]
2. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
[TBL] [Abstract][Full Text] [Related]
3. Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk.
Barboro P; Benelli R; Tosetti F; Costa D; Capaia M; Astigiano S; Venè R; Poggi A; Ferrari N
Carcinogenesis; 2020 Sep; 41(9):1246-1252. PubMed ID: 32525968
[TBL] [Abstract][Full Text] [Related]
4. Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.
Huang CK; Iwagami Y; Aihara A; Chung W; de la Monte S; Thomas JM; Olsen M; Carlson R; Yu T; Dong X; Wands J
PLoS One; 2016; 11(3):e0150336. PubMed ID: 26954680
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma.
Nagaoka K; Bai X; Ogawa K; Dong X; Zhang S; Zhou Y; Carlson RI; Jiang ZG; Fuller S; Lebowitz MS; Ghanbari H; Wands JR
Cancer Lett; 2019 May; 449():87-98. PubMed ID: 30768955
[TBL] [Abstract][Full Text] [Related]
6. A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma.
Aihara A; Huang CK; Olsen MJ; Lin Q; Chung W; Tang Q; Dong X; Wands JR
Hepatology; 2014 Oct; 60(4):1302-13. PubMed ID: 24954865
[TBL] [Abstract][Full Text] [Related]
7. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.
Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Bai X; Sun B; Hung MC; Liu L; Wands J; Dong X
Mol Cancer; 2019 Nov; 18(1):156. PubMed ID: 31694640
[TBL] [Abstract][Full Text] [Related]
8. Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis.
Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
Cancer Lett; 2020 Jul; 481():63-75. PubMed ID: 32145343
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update.
Hou G; Xu B; Bi Y; Wu C; Ru B; Sun B; Bai X
Bosn J Basic Med Sci; 2018 Nov; 18(4):297-304. PubMed ID: 30179586
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
11. Diverse molecular functions of aspartate β‑hydroxylase in cancer (Review).
Zheng W; Wang X; Hu J; Bai B; Zhu H
Oncol Rep; 2020 Dec; 44(6):2364-2372. PubMed ID: 33125119
[TBL] [Abstract][Full Text] [Related]
12. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.
Iwagami Y; Huang CK; Olsen MJ; Thomas JM; Jang G; Kim M; Lin Q; Carlson RI; Wagner CE; Dong X; Wands JR
Hepatology; 2016 Apr; 63(4):1213-26. PubMed ID: 26683595
[TBL] [Abstract][Full Text] [Related]
13. Small-molecule active pharmaceutical ingredients of approved cancer therapeutics inhibit human aspartate/asparagine-β-hydroxylase.
Brewitz L; Tumber A; Zhang X; Schofield CJ
Bioorg Med Chem; 2020 Oct; 28(20):115675. PubMed ID: 33069066
[TBL] [Abstract][Full Text] [Related]
14. LRH1 promotes pancreatic cancer metastasis.
Lin Q; Aihara A; Chung W; Li Y; Chen X; Huang Z; Weng S; Carlson RI; Nadolny C; Wands JR; Dong X
Cancer Lett; 2014 Aug; 350(1-2):15-24. PubMed ID: 24769073
[TBL] [Abstract][Full Text] [Related]
15. Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation.
Huang CK; Iwagami Y; Zou J; Casulli S; Lu S; Nagaoka K; Ji C; Ogawa K; Cao KY; Gao JS; Carlson RI; Wands JR
Cancer Lett; 2018 Aug; 429():1-10. PubMed ID: 29733964
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Novel Pyridine-Carboxylates as Small-Molecule Inhibitors of Human Aspartate/Asparagine-β-Hydroxylase.
Brewitz L; Tumber A; Thalhammer A; Salah E; Christensen KE; Schofield CJ
ChemMedChem; 2020 Jul; 15(13):1139-1149. PubMed ID: 32330361
[TBL] [Abstract][Full Text] [Related]
17. The JNK Signaling Pathway Is a Novel Molecular Target for S-Propargyl- L-Cysteine, a Naturally-Occurring Garlic Derivatives: Link to Its Anticancer Activity in Pancreatic Cancer In Vitro and In Vivo.
Wang W; Cheng J; Zhu Y
Curr Cancer Drug Targets; 2015; 15(7):613-23. PubMed ID: 26033085
[TBL] [Abstract][Full Text] [Related]
18. Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis.
Hsieh CC; Shyr YM; Liao WY; Chen TH; Wang SE; Lu PC; Lin PY; Chen YB; Mao WY; Han HY; Hsiao M; Yang WB; Li WS; Sher YP; Shen CN
Oncotarget; 2017 Jan; 8(5):7691-7709. PubMed ID: 28032597
[TBL] [Abstract][Full Text] [Related]
19. Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport.
Nagarajan A; Dogra SK; Sun L; Gandotra N; Ho T; Cai G; Cline G; Kumar P; Cowles RA; Wajapeyee N
Mol Cell; 2017 Aug; 67(4):685-701.e6. PubMed ID: 28803777
[TBL] [Abstract][Full Text] [Related]
20. Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.
Bi YL; Min M; Shen W; Liu Y
Tumour Biol; 2016 Nov; 37(11):15145-15155. PubMed ID: 27677287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
